Akanda corp. announces plans to be among international first movers pending completion of landmark change in us drug policy

London, united kingdom--(newsfile corp. - may 10, 2024) - akanda corp. (nasdaq: akan) ("akanda" or the "company"), an international medical cannabis company, today announces it is actively following the landmark change in federal us policy to reschedule cannabis under the controlled substances act ("csa"). it has been widely reported that as of april 30, 2024 the dea plans to reclassify cannabis as a schedule iii substance.
AKAN Ratings Summary
AKAN Quant Ranking